Results 371 to 380 of about 532,411 (388)

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly  

Long-term benefit of enzyme replacement therapy in Pompe disease

Neurology, 2017
E. Kuperus, M. Kruijshaar, S. Wens, J. D. de Vries, M. Favejee, J. C. van der Meijden, D. Rizopoulos, E. Brusse, P. Van Doorn, A. T. van der Ploeg, N. A. van der Beek   +10 more
semanticscholar   +1 more source

Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement

Clinical pharmacology and therapy, 2018
N. Guérard, D. Oder, P. Nordbeck, C. Zwingelstein, O. Morand, R. Welford, J. Dingemanse, C. Wanner   +7 more
semanticscholar   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

Enzyme Replacement Therapy

2008
openaire   +1 more source

Enzyme replacement therapy and beyond—in memoriam Roscoe O. Brady, M.D. (1923–2016)

Journal of Inherited Metabolic Disease, 2017
M. Ries
semanticscholar   +1 more source

Pompe's disease: Enzyme replacement therapy

Drugs of the Future, 2007
null Koeberl, D.D., null Kishnani, P.S.
openaire   +1 more source

ENZYME REPLACEMENT THERAPY IN MPS1

Neuropediatrics, 2006
L De Meirleir, A Benatar, A Van Hulle, G Van Berlaer   +3 more
openaire   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly